Accurate screening system for cervical cancer

Abstract

The invention discloses an accurate screening system for a cervical cancer. The system comprises a digital electronic colposcope, an expander, an intelligent terminal and a cervical disease managementplatform; the digital electronic colposcope can be fixedly arranged at the rear end of the expander and is used for observing a cervix uteri and transmitting an observed cervix uteri image to the intelligent terminal through a network; the intelligent terminal is provided with a colposcope examination APP, and is used for receiving and displaying the cervix uteri image observed by the digital electronic colposcope and guiding accurate sampling of the cervix uteri under a visual condition, and the cervix uteri image is further uploaded to the cervix uteri disease management platform; and the cervical disease management platform comprises a cervical disease cloud database and is used for remotely sharing screened cervical images by medical experts. According to the accurate screening systemfor the cervical cancer, the accuracy of the accurate screening of the cervical cancer is remarkably improved, and meanwhile comprehensive management of screening, diagnosis and follow-up visit of female cervical diseases is achieved.

Description

technical field [0001] The invention relates to a medical system based on the Internet and cloud data, in particular to a precise screening system for cervical cancer. Background technique [0002] Cervical cancer is the most common malignant tumor in women. There are about 500,000 new cases of cervical cancer every year in the world, and about 200,000 people die from cervical cancer [CA Cancer J Clin.2005, 55:74]. 80% of them occurred in relatively poor countries, the main reason being the lack of effective screening methods and treatment programs [Obstet Gyneclo Clin North Am,2007,34:739]. According to data published by the National Cancer Center in 2019, there were about 100,000 new cases of cervical cancer in my country in 2015, and about 30,500 deaths [CA Cancer J Clin.2016,66:115. Chinese Journal of Oncology, 2019, 41:19. ]. According to literature estimates, by the end of 2018, the incidence of cervical cancer in my country will reach 150,000. The incidence of cervi...

AI Technical Summary

Problems solved by technology

However, in actual work, factors such as the operator's sense of responsibility, technical level, the structure and quality of the equipment used to obtain materials, and the location of the lesion will cause the sampling to be inaccurate, resulting in false negative test results, delaying the diagnosis and treatment time of the disease [cervix Cancer Cao Zeyi 2018 Viewpoint. Science and Technology Literature Press]

[0006] 2. Process ineffective management

The screening work in various places is not systematic, and an electronic traceable chronic disease follow-up system and platform have not been formed, so it is impossible to truly track and manage abnormal people

Especially people with abnormal virological or cytological results but poor compliance with medical treatment, out of control, still have a high risk of cancer. If the management is not in place, the early screening will be meaningless

[0008] 3. Screening technology is not integrated

However, none of the above-mentioned other methods can achieve "instant screening and immediate diagnosis", and it takes a period of time to wait for the results after sampling.

The disadvantages of VIA / VILI for naked eye observation are that visual observation consumes physical strength and is greatly affected by the external environment; VIA observation cannot be automatically timed; the results cannot be saved, and once the best observation period is missed, the experimental process cannot be reproduced in time. cause the detection to fail

Therefore, the sensitivity and specificity are low, endocervical lesions are difficult to detect, and quality control is difficult

[0012] 4. The prevention and control system has not formed a long-term mechanism

The cost of cervical cancer screening in western countries is high and slow, and it is not completely suitable for my country's national conditions

Images